Carbon Biosciences
Lexington
About Carbon Biosciences
Carbon Biosciences develops genetic medicines for the treatment of devastating diseases. They develop their vector using industrial-scale viral production platforms and can be used to deliver a wide-range of therapeutic modalities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $38.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: carbonbio.com
Industries & Categories
Biotechnology, Product Research, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/carbon-biosciences-48241 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.